Form 8-K - Current report:
SEC Accession No. 0001297184-25-000003
Filing Date
2025-02-27
Accepted
2025-02-27 16:33:14
Documents
14
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20250227x8k.htm   iXBRL 8-K 44818
2 EX-99.1 amph-20250227xex99d1.htm EX-99.1 895057
  Complete submission text file 0001297184-25-000003.txt   1101697

Data Files

Seq Description Document Type Size
3 EX-101.SCH amph-20250227.xsd EX-101.SCH 3498
4 EX-101.LAB amph-20250227_lab.xml EX-101.LAB 15361
5 EX-101.PRE amph-20250227_pre.xml EX-101.PRE 10385
17 EXTRACTED XBRL INSTANCE DOCUMENT amph-20250227x8k_htm.xml XML 4681
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 25679634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)